Symbols

CAH

Cardinal Health·NYSE

--(--)

CAH fundamentals

CAH Q2 2026 Earnings

Cardinal Health (CAH) released its earnings on Feb 5, 2026: revenue was 65.63B (YoY +18.76%), beat estimates; EPS was 2.63 (YoY +36.27%), beat estimates.

Revenue / YoY

65.63B

+18.76%

EPS / YoY

2.63

+36.27%

Report date

Feb 5, 2026

CAH Earnings Call Summary for Q2,2026

Revenue Growth: 19% YoY to $66 billion, driven by specialty (>$50B FY26), GMPD (3% growth), and other businesses (34% growth).
EPS Guidance Raise: $10.15-$10.35 (23-26% YoY growth), up from $10+ interim guidance.
Segment Strength: Pharma segment profit up 29% to $687M; GMPD profit up 108% to $37M; other businesses profit up 52% to $179M.
Strategic Acquisitions: Solaris Health MSO, ADS at-Home integration, and ION/GIA contributions driving growth.
Free Cash Flow: $1.8B year-to-date, with $750M buybacks at $173/share.
Operational Excellence: 10% improvement in product availability over 2 years, 38% operating earnings growth.

Earnings

EPS

Revenue

Revenue & Expenses

CAH has released its 2026 Q2 earnings report, with revenue of 65.63B, reflecting a YoY change of 18.75%, and net profit of 471.00M, showing a YoY change of 17.46%. The Sankey diagram below clearly presents CAH's revenue sources and cost distribution.

Key Indicators

Cardinal Health (CAH) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cardinal Health (CAH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Cardinal Health (CAH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Cardinal Health (CAH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown